
    
      This multi-centre, randomized, cross-over, prospective study will evaluate the occurrence of
      AF with AF pacing therapies programmed on (APP and VRR) and with AF therapies programmed off
      (APP and VRR) in patients with no known prior history of AF (all patients have a pacing
      indication). The occurrence of AF as well as time to first event and AF burden (frequecy and
      duration).
    
  